Glyxambi (empagliflozin and linagliptin) is a prescription medication that contains two diabetes medicines, empagliflozin (Jardiance) and linagliptin (Tradjenta), and is used to treat diabetes type 2. Serious side effects of Glyxambi include inflammation of the pancreas (pancreatitis), heart failure, an...
NCQA’s standards are well recognized, as the organization is celebrating its 25th year of working to improve healthcare quality by providing both standards of measurement and transparency for the benet of providers and consumers. For patients with diabetes, knowing that a healthcare provider is ...